AT374684B - Verfahren zur herstellung von waessrigen loesungen von in wasser nicht oder nur begrenzt loeslichen biologisch aktiven organischen verbindungen - Google Patents

Verfahren zur herstellung von waessrigen loesungen von in wasser nicht oder nur begrenzt loeslichen biologisch aktiven organischen verbindungen

Info

Publication number
AT374684B
AT374684B AT0204781A AT204781A AT374684B AT 374684 B AT374684 B AT 374684B AT 0204781 A AT0204781 A AT 0204781A AT 204781 A AT204781 A AT 204781A AT 374684 B AT374684 B AT 374684B
Authority
AT
Austria
Prior art keywords
organically
water
organic compounds
aqueous solutions
producing aqueous
Prior art date
Application number
AT0204781A
Other languages
German (de)
English (en)
Other versions
ATA204781A (de
Inventor
Jozsef Dipl Ing Chem D Szejtli
Eva Dipl Ing Chem Dr Bolla
Agnes Dipl Ing Chem Dr Stadler
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of ATA204781A publication Critical patent/ATA204781A/de
Application granted granted Critical
Publication of AT374684B publication Critical patent/AT374684B/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0204781A 1980-05-09 1981-05-08 Verfahren zur herstellung von waessrigen loesungen von in wasser nicht oder nur begrenzt loeslichen biologisch aktiven organischen verbindungen AT374684B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU801141A HU181703B (en) 1980-05-09 1980-05-09 Process for producing aqueus solutuins of water insoluble or hardly soluble vitamines, steroides, localanesthetics, prostanoides and non-steroid and antiphlogistic agents

Publications (2)

Publication Number Publication Date
ATA204781A ATA204781A (de) 1983-10-15
AT374684B true AT374684B (de) 1984-05-25

Family

ID=10953012

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0204781A AT374684B (de) 1980-05-09 1981-05-08 Verfahren zur herstellung von waessrigen loesungen von in wasser nicht oder nur begrenzt loeslichen biologisch aktiven organischen verbindungen

Country Status (7)

Country Link
JP (1) JPS574914A (fr)
AT (1) AT374684B (fr)
BE (1) BE888736A (fr)
CH (1) CH661517A5 (fr)
DE (1) DE3118218A1 (fr)
FR (1) FR2484252A1 (fr)
HU (1) HU181703B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187653A2 (fr) * 1985-01-10 1986-07-16 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Compositions pharmaceutiques remplaçant la bile et favorisant la digestion de graisses et procédé pour leur préparation

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936656A (ja) * 1982-08-23 1984-02-28 Teijin Ltd 新規包接化合物及びそれを活性成分とする薬剤
HU194858B (en) * 1982-12-03 1988-03-28 Chinoin Gyogyszer Es Vegyeszet Process for producing dibenzo/b,d/pirane derivatives and pharmaceutical compositions containing them
SE8305864D0 (sv) * 1983-10-25 1983-10-25 L E Medical Ogondroppar
EP0147685B1 (fr) * 1983-12-17 1989-04-26 Hoechst Aktiengesellschaft Ether de bêta-cyclodextrine et procédé pour sa préparation
EP0146841A3 (fr) * 1983-12-17 1986-11-20 Consortium für elektrochemische Industrie GmbH Ether mixte de bêta-cyclodextrine soluble dans l'eau et procédé pour sa préparation
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
JPH0651725B2 (ja) * 1985-02-28 1994-07-06 メルシャン株式会社 部分メチル化シクロデキストリン及びその製造方法
US6407079B1 (en) * 1985-07-03 2002-06-18 Janssen Pharmaceutica N.V. Pharmaceutical compositions containing drugs which are instable or sparingly soluble in water and methods for their preparation
JPS62123196A (ja) * 1985-11-22 1987-06-04 Nisshin Flour Milling Co Ltd プレドニゾロン包接化合物
JPH0637388B2 (ja) * 1986-02-17 1994-05-18 千寿製薬株式会社 水性液剤
DE3609116A1 (de) * 1986-03-14 1987-09-17 Herbe Wirkstoffe Gmbh Zubereitungen von gewuerzen oder drogen
KR890009402A (ko) * 1987-12-22 1989-08-01 베리 에이.뉴샘 피페리디닐시클로펜틸헵텐산 유도체를 함유한 수용성 제제
ES2037385T3 (es) * 1988-01-14 1993-06-16 Akzo N.V. Un procedimiento de manufactura de una preparacion farmaceutica para administracion local.
IE64346B1 (en) * 1988-01-19 1995-07-26 Moses Judah Folkman Growth inhibiting agent and the use thereof
DE3815902A1 (de) * 1988-05-10 1989-11-23 Schwarz Pharma Gmbh Einschlussverbindungen des 1-(4-(2-(5-chloro-2-methoxybenzamido)ethyl) -phenylsulfonyl)-3-cyclohexylharnstoffs mit (alpha)-,ss-,(gamma)-cyclodextrinen, jeweils diese enthaltendes pharmazeutisches praeparat und verfahren zu deren herstellung
JP2735122B2 (ja) * 1988-06-13 1998-04-02 旭化成工業株式会社 メキタジンの液状シロップ製剤
NL8801670A (nl) 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
FR2640137A1 (fr) * 1988-12-08 1990-06-15 Texinfine Sa Systemes transporteurs de principes actifs lipophiles et leur procede d'obtention
CA2017156A1 (fr) * 1989-06-02 1990-12-02 Sotoo Asakura Preparation de la substance fr115224 pour administration parenterale
SE8902235D0 (sv) * 1989-06-20 1989-06-20 Haessle Ab Novel cyclodextrin inclusion complexes
USRE34578E (en) * 1990-05-07 1994-04-05 Lubkin; Virginia Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
US5041434A (en) * 1991-08-17 1991-08-20 Virginia Lubkin Drugs for topical application of sex steroids in the treatment of dry eye syndrome, and methods of preparation and application
DE4207922A1 (de) * 1992-03-13 1993-09-23 Pharmatech Gmbh Wasserloesliche einschlussverbindungen und verfahren zu deren herstellung
DE4227569C1 (de) * 1992-08-20 1994-06-09 Inst Chemo Biosensorik Verfahren zum empfindlichen enzymatischen Nachweis von anorganischem Phosphat
JPH06157330A (ja) * 1992-11-27 1994-06-03 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法と用途
JPH0753396A (ja) * 1993-08-19 1995-02-28 Ensuiko Sugar Refining Co Ltd タキソールのサイクロデキストリン包接物，その製造法および用途
US5684169A (en) * 1992-11-27 1997-11-04 Ensuiko Sugar Refining Co., Ltd. Cyclodextrin inclusion complex of taxol, and method for its production and its use
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
JP2715240B2 (ja) * 1993-05-18 1998-02-18 株式会社第一ラジオアイソトープ研究所 放射性ヨウ素標識脂肪酸−シクロデキストリン複合体およびこれを含有するイメージング剤
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
NZ270077A (en) * 1993-12-14 1996-04-26 Lilly Co Eli Aqueous complexes of benzothiophenes and cyclodextrins
DE4405545A1 (de) * 1994-02-22 1995-08-31 Dietl Hans Fettlösliche Vitamine enthaltende Zubereitung zur oralen Applikation
JP3934705B2 (ja) * 1995-05-26 2007-06-20 ノバルティス ファーマ株式会社 サイクロデキストリン組成物
JP2006328090A (ja) * 1995-05-26 2006-12-07 Nobaruteisu Fuaama Kk サイクロデキストリン組成物
ATE298582T1 (de) 1996-04-19 2005-07-15 Alpha Therapeutic Corp Verfahren zur inaktivierung von viren und lyophilisierung von blutproteinen
KR19980033113A (ko) * 1996-10-25 1998-07-25 야스다케 히지 국소 마취제 수용액, 국소 마취제의 용해도를 개선시키는 방법, 신경독성이 감소된 국소 마취제 및 국소 마취제의 신경 독성을 감소시키는 방법
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
US6962944B2 (en) 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
US7074824B2 (en) 2001-07-31 2006-07-11 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
DE10200657B4 (de) * 2002-01-10 2010-12-09 Wacker Chemie Ag 2:1-Komplex aus β- oder γ-Cyclodextrin und α-Tocopherol
FR2835434B1 (fr) * 2002-02-01 2006-03-03 Lvmh Rech Utilisation cosmetique ou dermatologique de la vitamine a ou de ses esters, en association avec une beta-cyclodextrine partiellement methylee
CA2520522C (fr) 2003-03-28 2012-05-29 Ivax Corporation Preparations a base de cladribine permettant une administration orale et transmucosale amelioree
EP2272503B1 (fr) 2003-03-28 2013-03-20 Ares Trading S.A. Formulation orale de cladribine
CA2520523C (fr) 2003-03-28 2011-10-11 Ivax Corporation Formulations de la cladribine a administration par voie orale
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
DE102005017775A1 (de) * 2005-04-13 2006-10-19 Schering Ag Komplexe aus Vitamin D-Verbindungen oder deren Analoga mit einem 5Z,7E,10(19)-Trien-System und methlierten Derivaten des ß-Cyclodextrins
BR112015015042A2 (pt) * 2012-12-27 2017-07-11 Shell Int Research composição de aditivo, pré-mistura para uso numa composição de aditivo, formulação de combustível ou lubrificante, e, uso de uma ciclodextrina modificada de fórmula (i)
BR112015014028A2 (pt) 2012-12-27 2017-07-11 Shell Int Research composição de aditivo para uso em um combustível diesel, formulação de combustível diesel, e, uso de uma ciclodextrina modificada
EP3021832B9 (fr) 2013-07-19 2023-03-15 Boehringer Ingelheim Vetmedica GmbH Dérivés de la cyclodextrine éthérifiée préservés contenant une composition pharmaceutique liquide aqueuse

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5835968B2 (ja) * 1974-02-25 1983-08-05 帝人株式会社 サイクロデキストリン包接化合物の製造法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0187653A2 (fr) * 1985-01-10 1986-07-16 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Compositions pharmaceutiques remplaçant la bile et favorisant la digestion de graisses et procédé pour leur préparation
EP0187653A3 (en) * 1985-01-10 1987-08-26 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Pharmaceutical compositions replacing the bile and aidinpharmaceutical compositions replacing the bile and aiding the digestion of fats, and process for their preparatig the digestion of fats, and process for their preparation on

Also Published As

Publication number Publication date
CH661517A5 (de) 1987-07-31
HU181703B (en) 1983-11-28
DE3118218A1 (de) 1982-04-22
FR2484252A1 (fr) 1981-12-18
FR2484252B1 (fr) 1984-06-29
BE888736A (fr) 1981-08-28
JPS574914A (en) 1982-01-11
ATA204781A (de) 1983-10-15

Similar Documents

Publication Publication Date Title
AT374684B (de) Verfahren zur herstellung von waessrigen loesungen von in wasser nicht oder nur begrenzt loeslichen biologisch aktiven organischen verbindungen
AT379155B (de) Verfahren zur herstellung von waesserigen loesungen oder dispersionen von polyurethanen
AT379603B (de) Verfahren zur herstellung von neuen in wasser dispergierbaren oder loeslichen polyurethanen
AT381714B (de) Verfahren zur herstellung von polyurethanen
AT311904B (de) Verfahren zur Verhinderung von Ausfällungen in Wasser oder wässerigen Lösungen
AT371833B (de) Verfahren zur herstellung einer iso-alpha-saeuren enthaltenden waesserigen mischung
AT344673B (de) Verfahren zur herstellung von aldehyden oder alkoholen
AT364461B (de) Verfahren zur herstellung von pseudomonsaeure
AT371097B (de) Verfahren zur herstellung von o-methallyloxyphenol
ATA645879A (de) Verfahren zur herstellung von viskosen
ATA311179A (de) Verfahren zur herstellung von 6alpha-halogen -pregnadien-derivates
AT373602B (de) Verfahren zur herstellung von phosphorkohlenstoff-stickstoff-bindung enthaltenden verbindungen
ATA232878A (de) Verfahren zur herstellung von waesserigen melaminharzloesungen
AT374486B (de) Verfahren zur herstellung von 17beta-hydroxy-17
AT365209B (de) Verfahren zur herstellung von polymaleinsaeuren
AT380701B (de) Verfahren zur herstellung von monofilen
AT383603B (de) Verfahren zur herstellung von aminoplastharzen
ATA322779A (de) Verfahren zur herstellung von trichloraethylen
AT364345B (de) Verfahren zur herstellung von n-aethylaethylendiamin
AT360978B (de) Verfahren zur herstellung von isocyanaten
AT367017B (de) Verfahren zur herstellung von p-amino-diphenylamin
AT356911B (de) Verfahren zur herstellung von schichtstoffen
AT369399B (de) Verfahren zur herstellung von modifizierten alkydharzen
AT368140B (de) Verfahren zur herstellung von suspensionen oder loesungen von cyanurchlorid in wasserhaltigen organischen loesungsmitteln
ATA916078A (de) Verfahren zur herstellung von magnesiumsulfit-zellstoff

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee